Faheem Hasnain

(Mr. Faheem Hasnain)

Currently holds positions in Mirati Therapeutics Inc, Gossamer Bio Inc, Tocagen Inc and Kura Oncology Inc

Positions

Position Company Period
Chairman of the Board Mirati Therapeutics Inc Feb. 15, 2019 -
Executive Chairman of the Board Gossamer Bio Inc July 1, 2018 -
Independent Chairman of the Board Tocagen Inc Oct. 1, 2014 -
Lead Independent Director Kura Oncology Inc March 1, 2020 -
Independent Director Kura Oncology Inc April 1, 2015 - March 1, 2020
Chairman of the Board Immunic Inc Sept. 6, 2017 - April 12, 2019
Director Immunic Inc Aug. 11, 2016 - Sept. 6, 2017
Faheem Hasnain's trades of Gossamer Bio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-24 2025-03-21
PS Planned sale
22,682 -48.6%
8.00
USD 181,456 		22,682 -48.6% 8.00 USD 181,456
2024-06-24 2024-06-21
B Purchase
372,000 +7.4%
0.67
USD 250,282 		372,000 +7.4% 0.67 USD 250,282
2024-03-28 2024-03-27
S Sale
23,172 -16.2%
1.16
USD 26,773 		23,172 -16.2% 1.16 USD 26,773
2023-08-14 2023-08-11
B Purchase
10,791 +inf%
27.80
USD 299,990 		10,791 +inf% 27.80 USD 299,990
2023-03-22 2023-03-22
B Purchase
440,500 +10.9%
1.14
USD 503,580 		440,500 +10.9% 1.14 USD 503,580
2023-03-22 2023-03-21
B Purchase
269,389 +7.1%
1.20
USD 322,324 		269,389 +7.1% 1.20 USD 322,324
2023-03-22 2023-03-20
B Purchase
168,683 +4.7%
1.03
USD 174,486 		168,683 +4.7% 1.03 USD 174,486
2022-07-15 2022-07-15
B Purchase
138,696 +4.0%
7.21
USD 999,998 		138,696 +4.0% 7.21 USD 999,998
2022-03-24 2022-03-23
S Sale
19,035 -11.7%
8.92
USD 169,697 		19,035 -11.7% 8.92 USD 169,697
2020-10-14 2020-10-14
B Purchase
96,520 +2.9%
10.36
USD 999,995 		96,520 +2.9% 10.36 USD 999,995
2019-09-27 2019-09-27
B Purchase
10,000 +0.3%
16.80
USD 167,980 		10,000 +0.3% 16.80 USD 167,980
2019-06-03 2019-05-30
US Tocagen Inc (TOCA)
B Purchase
250 +0.1%
5.15
USD 1,287 		250 +0.1% 5.15 USD 1,287
2019-06-03 2019-05-30
US Tocagen Inc (TOCA)
B Purchase
3,890 +1.6%
5.30
USD 20,613 		3,890 +1.6% 5.30 USD 20,613
2019-06-03 2019-05-30
US Tocagen Inc (TOCA)
B Purchase
38,860 +19.2%
4.59
USD 178,414 		38,860 +19.2% 4.59 USD 178,414
2018-09-17 2018-09-13
US Immunic Inc (IMUX)
S Sale
118,243 -96.3%
0.44
USD 51,767 		118,243 -96.3% 0.44 USD 51,767
2018-09-17 2018-09-13
US Immunic Inc (IMUX)
S Sale
59,200 -32.5%
0.44
USD 25,912 		59,200 -32.5% 0.44 USD 25,912
2017-09-15 2017-09-14
US Immunic Inc (IMUX)
B Purchase
59,200 +48.2%
4.19
USD 247,870 		59,200 +48.2% 4.19 USD 247,870
2017-04-21 2017-04-19
US Tocagen Inc (TOCA)
B Purchase
100,000 +97.2%
10.00
USD 1,000,000 		100,000 +97.2% 10.00 USD 1,000,000
2016-08-15 2016-08-12
US Immunic Inc (IMUX)
B Purchase
118,243 +2627.6%
5.92
USD 699,999 		118,243 +2627.6% 5.92 USD 699,999
// ... existing code ... // ... rest of the file ...